IRIS
D'ANGELO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 647
AS - Asia 506
EU - Europa 257
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.415
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 614
SG - Singapore 250
HK - Hong Kong 155
IT - Italia 78
VN - Vietnam 48
CN - Cina 46
CA - Canada 33
DE - Germania 29
SE - Svezia 24
NL - Olanda 23
GB - Regno Unito 20
UA - Ucraina 19
FI - Finlandia 18
FR - Francia 15
AT - Austria 10
IE - Irlanda 10
BE - Belgio 4
AR - Argentina 2
CZ - Repubblica Ceca 2
JP - Giappone 2
LT - Lituania 2
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
EU - Europa 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
RO - Romania 1
SI - Slovenia 1
TH - Thailandia 1
TR - Turchia 1
Totale 1.415
Salva come PNG Salva come JPEG
Città #
Hong Kong 155
Fairfield 96
The Dalles 76
Singapore 51
Dong Ket 48
Ashburn 44
Chandler 43
Woodbridge 38
Jacksonville 36
Seattle 34
Wilmington 34
Toronto 30
Cambridge 29
Houston 22
Boardman 21
Helsinki 18
Amsterdam 12
Princeton 11
Dublin 10
New York 9
Ann Arbor 8
Düsseldorf 8
Porto Sant'elpidio 8
Centro 7
Vico Equense 7
Cancellara 5
Frankfurt am Main 5
London 5
Nuremberg 5
Brussels 4
Camerino 4
San Diego 4
Aprilia 3
Chiswick 3
Falkenstein 3
Los Angeles 3
Ogden 3
Ottawa 3
Bari 2
Brindisi 2
Brno 2
Buenos Aires 2
Lauterbourg 2
Maletto 2
Milan 2
Padova 2
Pignola 2
Portsmouth 2
Santa Clara 2
Shenzhen 2
Southwark 2
Tokyo 2
Acton 1
Baku 1
Beijing 1
Buffalo 1
Changsha 1
Chicago 1
Croydon 1
Geislingen an der Steige 1
Guangzhou 1
Jinan 1
Melbourne 1
Munich 1
Nanchang 1
Nanjing 1
Norwalk 1
Potenza 1
Rockville 1
Rome 1
San Francisco 1
Shanghai 1
Shaoyang 1
Speyer 1
Taranto 1
Tel Aviv 1
Tianjin 1
Vienna 1
Vientiane 1
Wuhan 1
Wuxi 1
Zurich 1
Totale 963
Salva come PNG Salva come JPEG
Nome #
From structure to function for the characterization of ERAP1 active site in Behçet syndrome. A novel polymorphism associated with known gene variations 147
Pistacia lentiscus Hydrosol: Untargeted Metabolomic Analysis and Anti-Inflammatory Activity Mediated by NF-κB and the Citrate Pathway 96
New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation 95
Correlation of Tumor Necrosis Factor-α −308G>A Polymorphism with Susceptibility, Clinical Manifestations, and Severity in Behçet Syndrome: Evidences from an Italian Genetic Case–Control Study 90
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 81
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 73
ERAP1 molecular characterization: Identification of a de novo allelic variant 69
Identification of a de novo NLRP3 gene variation in an Italian Behçet syndrome patient 63
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 62
A First Step for the Molecular Characterization of Neurological Involvement of Behçet Syndrome: an Italian Pivotal Study 51
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 38
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 18
Corticosteroid injection treatment for dactylitis in psoriatic arthritis 18
Assessing vitamin D levels in an anti-DFS70 positive population: New insights emerging 17
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study 17
Clinical phenotypes of Behçet’s syndrome in a large cohort of Italian patients: focus on gender differences 17
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 16
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 15
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial 15
The role of adalimumab in the treatment of heart block in HLA-B27-associated disease: a case description 15
Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 15
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 14
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 14
TNFα rs1800629 Polymorphism and Response to Anti-TNFα Treatment in Behçet Syndrome: Data from an Italian Cohort Study 14
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 14
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 14
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 14
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis 13
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 13
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 13
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey 13
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis 13
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review 13
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study 12
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study 12
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 12
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 11
Understanding the Biological Significance of Anti-DFS70 Antibodies: Effect of Biologic Therapies on Their Occurrence in Inflammatory Arthritis 11
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 11
Ankylosing Spondylitis - Axial Spondyloarthritis (2nd ed.) 10
Serum amyloid A in healthy subjects: assessment of reference value using ELISA method 10
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment? 10
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum 9
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 9
Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations 9
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 9
Morphologic, dynamic and high-resolution microscopy MRI in early-onset spondyloarthritis finger dactylitis 9
UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis 9
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 9
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 9
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 8
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists 8
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients 8
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 8
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 8
Toxicological considerations in the treatment of axial spondylo-arthritis 8
Real‐world effectiveness and persistence of golimumab as second‐line anti‐TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO‐BEYOND, a 12‐month prospective observational study 8
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 7
Harmonization of ANA testing challenge: quantification strategy to accurately predict end-point titers avoiding serial dilution 7
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment 7
Impact of the COVID-19 Pandemic on the Appropriateness of Diagnostic Pathways of Autoimmune Rheumatic Diseases 7
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology 7
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 7
Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie 6
Prevalence of Type 2 and Type 1 Diabetes in Psoriatic Arthritis 6
Reply to the letter to the editor: Dynamic contrast-enhanced MRI could assess the local disease activity of enthesitis and dactylitis in patients with spondyloarthritis 6
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study 6
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 6
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study 4
The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Behçet’s syndrome: a large Italian cohort study 4
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 4
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 3
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 3
Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab 3
The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis 1
Totale 1.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 1 1 3
2020/2021376 14 19 18 102 18 54 3 27 12 32 17 60
2021/2022141 15 15 28 18 7 5 13 7 10 4 0 19
2022/2023114 15 0 2 3 13 18 0 15 32 3 12 1
2023/202480 7 7 5 3 5 14 3 4 10 0 0 22
2024/2025785 5 2 29 148 88 31 159 70 220 33 0 0
Totale 1.511